Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory M Hogaboam

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
Pharmacology & Therapeutics|July 13, 2005
The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary diseaseCory M Hogaboam, Kristin J Carpenter, Jane M Schuh, et al.
The American Journal of Pathology|March 30, 2007
Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient miceElizabeth M Pierce, Kristin Carpenter, Claudia Jakubzick, et al.
Blood|November 28, 2002
Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysisSandra H P Oliveira, Dennis D Taub, James Nagel, et al.
Clinical Science (London, England : 1979)|January 10, 2003
Chemokines in the pathogenesis of liver disease: so many players with poorly defined rolesKenneth J Simpson, Neil C Henderson, Cynthia L Bone-Larson, et al.
Fibrosis (Hong Kong, China)|June 14, 2024
Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary FibrosisMilena S Espindola, David M Habiel, Ana Lucia Coelho, et al.
Mucosal Immunology|October 14, 2018
Characterization of CD28<sup>null</sup> T cells in idiopathic pulmonary fibrosisDavid M Habiel, Milena S Espindola, Chris Kitson, et al.
Experimental and Molecular Pathology|January 11, 2002
Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitisAkihiro Matsukawa, Nicholas W Lukacs, Cory M Hogaboam, et al.
The American Journal of Pathology|June 28, 2011
Therapeutic DNA vaccine reduces schistosoma mansoni-induced tissue damage through cytokine balance and decreased migration of myofibroblastsFabiani Gai Frantz, Toshihiro Ito, Karen Angélica Cavassani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cellsClaudia Jakubzick, Esther S Choi, Bharat H Joshi, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2009
Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitisAmrita D Joshi, Daniel J Fong, Sameer R Oak, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
Pharmacology & Therapeutics|July 13, 2005
The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary diseaseCory M Hogaboam, Kristin J Carpenter, Jane M Schuh, et al.
The American Journal of Pathology|March 30, 2007
Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient miceElizabeth M Pierce, Kristin Carpenter, Claudia Jakubzick, et al.
Blood|November 28, 2002
Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysisSandra H P Oliveira, Dennis D Taub, James Nagel, et al.
Clinical Science (London, England : 1979)|January 10, 2003
Chemokines in the pathogenesis of liver disease: so many players with poorly defined rolesKenneth J Simpson, Neil C Henderson, Cynthia L Bone-Larson, et al.
Fibrosis (Hong Kong, China)|June 14, 2024
Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary FibrosisMilena S Espindola, David M Habiel, Ana Lucia Coelho, et al.
Mucosal Immunology|October 14, 2018
Characterization of CD28<sup>null</sup> T cells in idiopathic pulmonary fibrosisDavid M Habiel, Milena S Espindola, Chris Kitson, et al.
Experimental and Molecular Pathology|January 11, 2002
Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitisAkihiro Matsukawa, Nicholas W Lukacs, Cory M Hogaboam, et al.
The American Journal of Pathology|June 28, 2011
Therapeutic DNA vaccine reduces schistosoma mansoni-induced tissue damage through cytokine balance and decreased migration of myofibroblastsFabiani Gai Frantz, Toshihiro Ito, Karen Angélica Cavassani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cellsClaudia Jakubzick, Esther S Choi, Bharat H Joshi, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2009
Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitisAmrita D Joshi, Daniel J Fong, Sameer R Oak, et al.
Pageof 20